zolpidem

(redirected from Zolpimist)
Also found in: Medical.
Related to Zolpimist: Edluar

zol·pi·dem

 (zōl′pə-dĕm′)
n.
A non-benzodiazepine sleep-inducing drug, C19H21N3O, used in its tartrate form to treat insomnia.

[(a)zol(e) + p(yrim)id(ine) + alteration of am(ide).]

zolpidem

(ˈzɒlpɪˌdɛm)
n
a drug used to treat insomnia
Translations

zolpidem

n zolpidem m
Mentioned in ?
References in periodicals archive ?
Blast-exposure status, Marine Corps service, an infantry MOS, PTSD diagnosis, unprotected noise exposure, TCS use, hyperacusis/noise sensitivity, and zolpidem (eg, Edluar, Zolpimist, Intermezzo, Ambien) use were each significantly associated with tinnitus in the bivariate analysis.
M2 EQUITYBITES-February 3, 2015-NovaDel Pharma sell remaining ZolpiMist assets to Amherst Pharmaceuticals
M2 PHARMA-February 3, 2015-NovaDel Pharma sell remaining ZolpiMist assets to Amherst Pharmaceuticals
Current brands include DexPak, Bupap, TussiCaps, Orbivan, Zolpimist and Zolvit.
In 2005, 6,000 emergency-room cases nationwide involved Ambien and other medications containing the hypnotic drug zolpidem--such as Ambien CR, Edluar and Zolpimist.
A Zolpidem (generic), sold also under brand names Ambien, Ambien CR (extended release), Edluar (sublingual, which means under the tongue), and Zolpimist (oral spray), has been found to cause next-morning impairment for activities that require patients to be alert, including driving.
Food and Drug Administration has announced new, lower dosing requirements for certain sleep drugs that contain zolpidem, including Ambien, Ambien CR, Edluar, and ZolpiMist.
Nausea and vomiting are treated with Alliance Pharma's Buccastem and GlaxoSmithKline's Zofran, while Columbia Labs features a testosterone replacement with Striant SR, and NovaDel appeals to insomnia patients with Zolpimist.
Zolpidem is a generic drug that is marketed under a number of different brand names, including Ambien, Zolpimist, Edluar, Hypogen, Somidem and Ivedal.
PK) on Friday confirmed the sale of the remaining assets of the ZolpiMist NDA, a license agreement and related global intellectual property to Amherst Pharmaceuticals.
This transaction, as contemplated, does not include the NitroMist or ZolpiMist intellectual property or licenses.
Evidence of this association was so compelling, the Food and Drug Administration recently announced that it is requiring manufacturers of Ambien, Ambien CR, Zolpimist, and Edluar, sleep aids that contain zolpidem, to lower recommended doses.